Three venture-backed medical device firms raised more than $400 million through IPOs last quarter, Red Herring reports. Topping the list of money makers was Sunnyvale, CA-based Accuray, maker of the CyberKnife Robotic Radiosurgery System for treating tumors throughout the body with minimal damage to the surrounding tissue. The company’s February 8 debut included underwriters JP Morgan, UBS, Piper Jaffray & Co., and Jefferies & Co., according to the Associated Press. And Venture Capital Access Online notes, “Venture investors in Accuray include Marubeni Corporation and several undisclosed funds.” The offering, which raised some $288 million, culminated in a recent $1.2 billion…
Author: Global Cancer Consortium
Chatsworth, CA-based North American Scientific announced yesterday the appointment of John Rush as president and CEO. The med tech company, which makes radioisotope products for the treatment of cancer, lured Rush from Sanarus Medical of Pleasanton, CA. Rush, 48, had been with Sanarus since 2002. Prior to that, he was president and CEO of Micro Therapeutics (now owned by ev3). He has also done stints at Scimed Life Systems/Boston Scientific and Cilco/CooperVision/Alcon Surgical.